Jiangsu Hengrui Medicine Co., Ltd.

This study tested whether adding rivoceranib to camrelizumab works better than camrelizumab alone to keep liver cancer from returning after surgery or ablation. It involved 251 people with a high risk of recurrence. The main goal was to see how long participants stayed cancer-fre…

This early-phase study tested an experimental cancer pill, HRS7415, in 38 adults with advanced solid tumors that had spread. The main goals were to check the drug's safety, find the best dose, and see how the body processes it. This is a first step to see if the drug might help c…

This study tested a new tablet called HR091506 in 765 adults with gout and high uric acid. The goal was to see if it could lower uric acid levels better than an existing drug, febuxostat. Participants took the medicine for 28 weeks, and doctors checked their uric acid levels and …

This study tested whether a new medicine called HR17031 works better than insulin glargine for controlling blood sugar in Chinese adults with type 2 diabetes. About 400 people whose diabetes was not well controlled with oral medications took part. The main goal was to see changes…

This study tested a new drug, HR19042, in 316 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug can reduce protein in the urine and protect kidney function compared to a placebo. The trial is now complete, and results will help determine the best dose…

This study tested a combination of drugs (camrelizumab, chemotherapy, and apatinib) as a first treatment for people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. The goal was to see if this combo helps people live longer compared to …

This early-phase study tested an experimental drug called SHR-A1811 in 101 people with advanced stomach or colorectal cancers that have a specific protein (HER2). The main goals were to check safety, find the right dose, and see if the drug can shrink tumors. Participants had can…

This study tested whether a new injectable drug, HR17031, works better than the standard insulin glargine for controlling blood sugar in adults with type 2 diabetes. About 393 participants who were already on basal insulin and metformin took part. The main goal was to see changes…

This early-phase study tested a new drug called SHR-A1811 in 396 adults with advanced solid tumors that have a specific marker (HER2) and have stopped responding to standard treatments. The main goals were to check the drug's safety and how the body processes it, while also looki…

This study tested a combination of two drugs, SHR-1210 (an immunotherapy) and apatinib (a targeted therapy), in 190 adults with advanced liver cancer that had stopped responding to or could not tolerate prior treatment. The goal was to see if the combo could shrink tumors and how…

This study tested a targeted drug called pyrotinib against standard chemotherapy (docetaxel) in 151 people with advanced non-squamous lung cancer that has a specific HER2 mutation. Participants had already tried platinum-based chemo without success. The goal was to see if pyrotin…

This study tested whether an oral medication (SHR7280) works as well as a standard injectable drug (ganirelix) for preventing early ovulation in women undergoing IVF. About 317 women participated. The goal was to see if the pill could offer a more convenient option without reduci…

This study tested a new drug called HRS-9190 in 70 adults having planned surgery. The drug is a muscle relaxant given to help doctors place a breathing tube more easily during anesthesia. Researchers compared HRS-9190 to a standard muscle relaxant to see if it works as well and i…

This study tested a drug called remimazolam tosilate to keep ICU patients calm and comfortable while they are on a breathing machine for three days or more. Researchers wanted to see if the drug works well and is safe. The trial included 24 adults aged 18 to 80 with a healthy wei…

This study tested a new sedative called remimazolam tosilate in 214 ICU patients who were on breathing machines. The goal was to see if it could safely keep patients at the right level of calm without needing extra rescue medicine. The trial compared it to another sedative to che…

This study looked at how a new injection called HRS-8427 changes the way the body processes two other drugs (bupropion and midazolam) in 14 healthy adults. The goal was to see if HRS-8427 affects liver enzymes that break down many medications. Results will help doctors understand…

This study tested a pain drug called SHR8554 in 20 people—some with kidney problems and some healthy. The goal was to see how the drug moves through the body and if it's safe. Results help doctors understand how to use this drug in patients with kidney issues.

This early-stage study tested a new drug called HRS-9190 in 53 healthy adults aged 18 to 45. The main goal was to check its safety and how the body processes it at different doses. Researchers measured side effects and drug levels in the blood. This study did not treat any diseas…

This study looked at how the drug HR17031 is processed in people with different levels of kidney function, from mild to severe kidney disease and even end-stage disease. It included 24 adults aged 18 to 70. The goal was to measure drug levels in the blood, not to treat diabetes. …

This early-stage study tested a single injection of a new drug called SHR-3167 against standard insulin glargine in 24 healthy men. The goal was to compare how the body handles blood sugar after each drug, not to treat any disease. No direct benefit to participants was expected, …

This study looked at how the antibiotic rifampicin changes the way the body processes HRS-5041, an experimental drug for prostate cancer. Sixteen healthy men took HRS-5041 alone and then with rifampicin to compare drug levels. The goal was to gather safety and dosing information,…

This study tested whether a new version of a long-acting painkiller (bupivacaine liposome injection) works the same as the approved drug. 36 healthy adults received both versions, and researchers measured drug levels in their blood. The goal was to confirm the new version is equi…

This study looked at how a new drug called SHR7280 affects the way the body processes other common medicines. Twenty healthy men took SHR7280 along with several other drugs to see if their levels in the blood changed. The goal was to gather safety and interaction information, not…

This study looked at the safety of a drug called remimazolam (Rebenin) when used in real-world medical settings for general anesthesia and sedation during bronchoscopy. Researchers observed over 1,200 patients in China to track any side effects. The goal was to gather safety info…

This early-stage study tested a new drug called HR011408 in 62 healthy adults to see if it is safe and how the body processes it. The study did not aim to treat diabetes, but to gather important safety information before further testing. Participants received the drug in two diff…

This early-stage study tested a new drug called HRS-9190 in 49 healthy adults to see if it is safe and how the body processes it. The drug is designed to relax muscles, and researchers measured side effects, drug levels in the blood, and its effects on heart rhythm. This is a fir…